Cynata Therapeutics Ltd has released a press release.
Progress Toward Clinical Trial in Diabetic Foot Ulcers
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Cynata signs Licence Agreement with TekCyte
- First Patient Enrolled in Cynata MEND Clinical Trial
- Cynata Therapeutics Expands MEND clinical trial in COVID-19 and Respiratory Failure
- Cynata Expands trial in COVID-19 & Respiratory Failure
- New Preclinical Study to Investigate the High Potency of Cymerus™ MSCs
Later from Cynata Therapeutics
- Ethics Approval for Cynatas Clinical Trial in DFU
- Cynata Receives Notice of Allowance from US Patent Office
- Further Canadian Patent for Cynata
- Further Patents for Cynata Unique Cymerus Technology
- Cynata Enters into a New Strategic Partnership with Fujifilm
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics